assay · intermediate · partly written
Ribosome profiling (Ribo-seq)
Sequences the roughly 30-nucleotide pieces of mRNA a ribosome shields from a nuclease, giving where ribosomes sit across the transcriptome.
Also called: Ribo-seq, ribosome footprinting, GTI-seq, QTI-seq
Seeing starts more
Four designs freeze ribosomes at starts: harringtonine (mouse stem cells; 13,454 candidate starts in about 5,000 transcripts), puromycin then cycloheximide (human THP-1: 7,251 putative starts in 4,364 transcripts), lactimidomycin (GTI-seq; HEK293 and mouse) and a variant, QTI-seq, that adds the drug in lysis buffer to avoid re-initiation at 37 C. Site counts for the same cells differ by protocol; the per-protocol counts for the lactimidomycin and QTI-seq papers could not be re-opened and are not given. 123
Reported, not yet replicated
Cost and effort, and the cycloheximide problem more
A protocol paper gives 5 to 7 days of hands-on work (read through a summarising tool). Cycloheximide pre-treatment distorts yeast profiles; in human 293T cells profiles were largely stable but density rose in the first about 15 codons, and in HeLa reporters the drug did not stop near-cognate initiation. 456
Reported, not yet replicated
Noncanonical ORFs more
Of 7,264 human Ribo-seq ORFs in one standardised catalogue, 609 had mass-spectrometry support and 75 showed coding conservation; other authors argue at least 7,000 are translated and that counts vary about 30-fold between pipelines. A CRISPR screen reports hundreds needed for growth (abstract). 78
Contested
Question answered
Readout physical
A count of sequencing reads from ribosome-protected fragments, with a footprint position and, in good data, a three-nucleotide periodicity. 9
Reported, not yet replicated
Not measured
That a stable, functional protein results. A review of the human catalogue states ribosome profiling 'does not demonstrate actual protein existence'; ribosome profiling agreed with only 29% of alternative N-termini found by mass spectrometry in Jurkat cells against 89% of annotated ones. 710
Reported, not yet replicated
Setting
Still open here
- The 2009 paper's footprint length, frame fraction and R2 values could not be re-opened at source check and are not given.
- Per-protocol human start-site counts for GTI-seq and QTI-seq: not confirmed.
Not yet written: Where in cascade, Sample prep, Conditions, Throughput class, Throughput, Time per run, Cost, Engineerable variants, Use cases, Before after, Capital, Emerging, ML role, Data availability.
Linked from
- N-terminal proteomics (COFRADIC)
- Alternative start codons and two protein forms
- Translation initiation: scanning and start-codon choice
- Nicholas T. Ingolia
- For how many human genes does a second start codon make a second protein with its own job?
- How many translated noncanonical ORFs make functional products?
Sources
- Ingolia NT, Lareau LF, Weissman JS. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes.. Cell (2011). paper; opened 2026-11-17 all records citing this
- Fritsch C, Herrmann A, Nothnagel M, et al.. Genome-wide search for novel human uORFs and N-terminal protein extensions using ribosomal footprinting.. Genome Res (2012). paper; opened 2026-11-17 all records citing this
- Lee S, Liu B, Lee S, et al.. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution.. Proc Natl Acad Sci U S A (2012). paper; opened 2026-11-17 all records citing this
- Ingolia NT, Brar GA, Rouskin S, et al.. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments.. Nat Protoc (2012). paper; opened 2026-11-17 all records citing this
- Sharma P, Wu J, Nilges BS, et al.. Humans and other commonly used model organisms are resistant to cycloheximide-mediated biases in ribosome profiling experiments.. Nat Commun (2021). paper; opened 2026-11-17 all records citing this
- Kearse MG, Goldman DH, Choi J, et al.. Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors.. Genes Dev (2019). paper; opened 2026-11-17 all records citing this
- Prensner JR, Abelin JG, Kok LW, et al.. What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?. Mol Cell Proteomics (2023). paper; opened 2026-11-17 all records citing this
- Chen J, Chen J, Brunner AD, et al.. Pervasive functional translation of noncanonical human open reading frames.. Science (2020). paper; opened 2026-11-17 all records citing this
- Ingolia NT, Ghaemmaghami S, Newman JR, et al.. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science (2009). paper; opened 2026-11-17 all records citing this
- Gawron D, Ndah E, Gevaert K, et al.. Positional proteomics reveals differences in N-terminal proteoform stability.. Mol Syst Biol (2016). paper; opened 2026-11-17 all records citing this
- Fedorova AD, Kiniry SJ, Andreev DE, et al.. Thousands of human non-AUG extended proteoforms lack evidence of evolutionary selection among mammals.. Nat Commun (2022). paper; opened 2026-11-17 all records citing this
Where it sits on the map
History of this record (5)
This record has been changed 5 times, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.
- Status
- partly written
- Last updated
- 2026-11-19
- Record
- content/assays/ribosome-profiling.json